Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intertransverse Process Block to Improve Quality of Recovery After Cardiac Surgery With Sternotomy
NCT06926764Withdrawn
- Sponsor
- The Chinese University of Hong Kong
- Start
- Nov 2025
- Primary completion
- Nov 2027
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of levobupivacaine in acute postoperative pain (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Quality of Recovery-15 at 72 hours. Planned start Nov 2025; status: withdrawn.
02
Drugs
levobupivacaine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT06926764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06926764.